PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25019N0305VISN 10 pharmaceutical reverse distribution - — Returns 'R' Us, Inc

PoP ended Aug 11, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

250-Network Contract Office 10 (36C250)

Awarding office

Returns 'R' Us, Inc

Recipient

Aug 11, 2023

PoP end

$-496,645.27

Obligated

$2.9M

Potential

493110

NAICS

Q517

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Returns 'R' Us, Inc — $90

Contract facts

Federal

Contract number36C25019N0305

Also listed as36C250-19-N-0305

Also listed as36W79718D0002-36C25019N0305

Agency250-Network Contract Office 10 (36C250)

Awarding office250-Network Contract Office 10 (36C250)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentReturns 'R' Us, Inc

CAGE1PUE0

UEID4VCRL38H9C9

NAICS493110

No full NAICS 493110 intel page yet. Browse NAICS intelligence

PSCQ517

Parent IDIQ / IDV36W79718D0002

Place of performanceINDIANAPOLIS IN

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startDec 1, 2018

PoP end (current)Aug 11, 2023

PoP end (w/ options)Oct 31, 2023

Obligated$-496,645.27

Current value$1.3M

Potential value$2.9M

VISN 10 PHARMACEUTICAL REVERSE DISTRIBUTION - ALL FACILITIES - FY20 CLOSURE DATE EXTENDED. is a federal award for 250-Network Contract Office 10 (36C250) held by Returns 'R' Us, Inc. Estimated value $2.9M ($-496,645.27 obligated). Current period of performance ends Aug 11, 2023 (potential Oct 31, 2023). Place of performance: INDIANAPOLIS IN.

VISN 10 PHARMACEUTICAL REVERSE DISTRIBUTION - ALL FACILITIES - FY20 CLOSURE DATE EXTENDED.

Recompete timing

Public

● Past PoP end (1106 days ago)

Current PoP ended Aug 11, 2023 (1106 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25019N0305?

36C25019N0305 (VISN 10 pharmaceutical reverse distribution -) is a 250-Network Contract Office 10 (36C250) award with a potential value of $2.9M, currently held by Returns 'R' Us, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C250-19-N-0305?

36C250-19-N-0305 is the dashed form of PIID 36C25019N0305 (VISN 10 pharmaceutical reverse distribution -), held by Returns 'R' Us, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25019N0305?

250-Network Contract Office 10 (36C250) awarded 36C25019N0305 to Returns 'R' Us, Inc (potential $2.9M).

Who is the incumbent on 36C25019N0305?

Returns 'R' Us, Inc is the incumbent. The current period of performance ends Aug 11, 2023.

When does Returns 'R' Us, Inc’s 36C25019N0305 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 11, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Apr 4, 2024 · refreshed monthly